A Designation Is a Starting Gun, Not a Finish Line
Orphan designation gets read as a milestone reached. It is an incentive granted before the work is done, and thymosin alpha-1 shows the difference.
Shop by category
Growth Hormone Axis ResearchRegeneration ResearchPeptide BioregulatorsCognitive & Neuropeptide ResearchMetabolic & Cellular ResearchMelanocortin & Endocrine ResearchDermal Peptide ResearchImmune & Thymic ResearchNotes from the bench and from the business: sourcing, testing, handling practice, and how we run a research peptide supplier.
For per-compound evidence reviews see the Research Hub, and for chemistry and handling references see the Reference Library.
Written for researchers, on sourcing, testing, handling practice, and how the store is run.
Orphan designation gets read as a milestone reached. It is an incentive granted before the work is done, and thymosin alpha-1 shows the difference.
PT-141 and melanotan II get treated as near-enough the same thing. One is named on an FDA safety-risk list and one is not, and the split is documented.
Selank is tuftsin, a fragment of an antibody, with three amino acids added at one end for a single stated purpose: to stop it degrading before it can act.
Almost everything in pharmacology starts by binding a receptor. The claim made for these peptides is that they skip that step and reach the gene itself.
A cell trims its proteins and discards the offcuts. DNSP-11 is eleven amino acids from one of those offcuts, and whether a living body makes it is an open question.
The names record the organ each compound's original extract came from, and that origin is also the series' central scientific claim.
The origin story everyone repeats about BPC-157 is close to right. The precise version is more interesting, and it changes how you read the whole literature.
The trials that won tesamorelin its approval were sponsor-funded, as approval trials are. What happened next is the part worth paying attention to.
Thymosin beta-4 is 43 amino acids long. The part that binds actin is six of them, and working out which six is a small masterpiece of patient science.
The 1973 paper that introduced GHK had nothing to do with skin, or with copper. How a tripeptide from blood took fifteen years to become a matrix molecule.
MOTS-c sits inside a mitochondrial gene whose job was never to make proteins. The discovery story, and what a sequence in a database does and doesn't prove.
A convincing blue color is easy to fake. Here's the plain-English version of the two checks that actually prove GHK-Cu's copper is real.